BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Edmonds BK, Hodge JA, Rietschel RL. Alpha 1-antitrypsin deficiency-associated panniculitis: case report and review of the literature. Pediatr Dermatol. 1991;8:296-299. [PMID: 1792202 DOI: 10.1111/j.1525-1470.1991.tb00937.x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 30] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Vignaud H, Cullin C, Bouchecareilh M. [Alpha-1 antitrypsin deficiency: A model of alteration of protein homeostasis or proteostasis]. Rev Mal Respir 2015;32:1059-71. [PMID: 26386628 DOI: 10.1016/j.rmr.2015.05.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
2 Geraminejad P, DeBloom JR 2nd, Walling HW, Sontheimer RD, VanBeek M. Alpha-1-antitrypsin associated panniculitis: the MS variant. J Am Acad Dermatol. 2004;51:645-655. [PMID: 15389208 DOI: 10.1016/j.jaad.2003.12.053] [Cited by in Crossref: 44] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
3 Requena L, Sánchez Yus E. Panniculitis. Part II. Mostly lobular panniculitis. J Am Acad Dermatol 2001;45:325-61; quiz 362-4. [PMID: 11511831 DOI: 10.1067/mjd.2001.114735] [Cited by in Crossref: 332] [Cited by in F6Publishing: 149] [Article Influence: 16.6] [Reference Citation Analysis]
4 Esnault VL, Testa A, Audrain M, Rogé C, Hamidou M, Barrier JH, Sesboüé R, Martin J, Lesavre P. Alpha1-antitrypsin genetic polymorphism in ANCA-positive systemic vasculitis. Kidney International 1993;43:1329-32. [DOI: 10.1038/ki.1993.186] [Cited by in Crossref: 138] [Cited by in F6Publishing: 110] [Article Influence: 4.9] [Reference Citation Analysis]
5 Torrelo A, Hernández A. Panniculitis in children. Dermatol Clin 2008;26:491-500, vii. [PMID: 18793982 DOI: 10.1016/j.det.2008.05.010] [Cited by in Crossref: 33] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
6 Dowd SK, Rodgers GC, Callen JP. Effective treatment with α1-protease inhibitor of chronic cutaneous vasculitis associated with α1-antitrypsin deficiency. Journal of the American Academy of Dermatology 1995;33:913-6. [DOI: 10.1016/0190-9622(95)90436-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
7 Mwirigi NW, Thomas CF. Hypersensitivity vasculitis with leukocytoclastic vasculitis associated with alpha-1-proteinase inhibitor. Case Rep Med 2009;2009:941258. [PMID: 20204065 DOI: 10.1155/2009/941258] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Greulich T, Nell C, Herr C, Vogelmeier C, Kotke V, Wiedmann S, Wencker M, Bals R, Koczulla AR. Results from a large targeted screening program for alpha-1-antitrypsin deficiency: 2003 - 2015. Orphanet J Rare Dis 2016;11:75. [PMID: 27282198 DOI: 10.1186/s13023-016-0453-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
9 Corley M, Solem A, Phillips G, Lackey L, Ziehr B, Vincent HA, Mustoe AM, Ramos SBV, Weeks KM, Moorman NJ, Laederach A. An RNA structure-mediated, posttranscriptional model of human α-1-antitrypsin expression. Proc Natl Acad Sci U S A 2017;114:E10244-53. [PMID: 29109288 DOI: 10.1073/pnas.1706539114] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
10 Lyon MJ. Metabolic panniculitis: alpha-1 antitrypsin deficiency panniculitis and pancreatic panniculitis. Dermatol Ther. 2010;23:368-374. [PMID: 20666824 DOI: 10.1111/j.1529-8019.2010.01337.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
11 Cox DW. α1-Antitrypsin: A Guardian of Vascular Tissue. Mayo Clinic Proceedings 1994;69:1123-4. [DOI: 10.1016/s0025-6196(12)61385-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
12 American Thoracic Society; European Respiratory Society. American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med. 2003;168:818-900. [PMID: 14522813 DOI: 10.1164/rccm.168.7.818] [Cited by in Crossref: 612] [Cited by in F6Publishing: 442] [Article Influence: 43.7] [Reference Citation Analysis]
13 Ferrarotti I, Carroll TP, Ottaviani S, Fra AM, O'Brien G, Molloy K, Corda L, Medicina D, Curran DR, McElvaney NG, Luisetti M. Identification and characterisation of eight novel SERPINA1 Null mutations. Orphanet J Rare Dis 2014;9:172. [PMID: 25425243 DOI: 10.1186/s13023-014-0172-y] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
14 Farmer KL. Additional Tests of Interest to the Dermatologist. Dermatologic Clinics 1994;12:191-9. [DOI: 10.1016/s0733-8635(18)30212-2] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
15 Sabbagh DK, Barmayehvar B, Nguyen T, Edgar RG, Turner AM. Managing panniculitis in alpha-1 antitrypsin deficiency: Systematic review of evidence behind treatment. WJD 2018;7:1-8. [DOI: 10.5314/wjd.v7.i1.1] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
16 Audrain MAP, Sesboüé R, Baranger TAR, Elliott J, Testa A, Martin J, Lockwood CM, Esnault VLM. Analysis of anti‐neutrophil cytoplasmic antibodies (ANCA): frequency and specificity in a sample of 191 homozygous (PiZZ) alpha1‐antitrypsin‐deficient subjects. Nephrology Dialysis Transplantation 2001;16:39-44. [DOI: 10.1093/ndt/16.1.39] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
17 Blanco I, Lipsker D, Lara B, Janciauskiene S. Neutrophilic panniculitis associated with alpha-1-antitrypsin deficiency: an update. Br J Dermatol 2016;174:753-62. [DOI: 10.1111/bjd.14309] [Cited by in Crossref: 30] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
18 Carroll TP, O'Connor CA, Floyd O, McPartlin J, Kelleher DP, O'Brien G, Dimitrov BD, Morris VB, Taggart CC, McElvaney NG. The prevalence of alpha-1 antitrypsin deficiency in Ireland. Respir Res 2011;12:91. [PMID: 21752289 DOI: 10.1186/1465-9921-12-91] [Cited by in Crossref: 54] [Cited by in F6Publishing: 41] [Article Influence: 5.4] [Reference Citation Analysis]
19 Korver G, Liu C, Petersen M. alpha1-Antitrypsin deficiency presenting with panniculitis and incidental discovery of chronic obstructive pulmonary disease. Int J Dermatol. 2007;46:1078-1080. [PMID: 17910720 DOI: 10.1111/j.1365-4632.2006.03067.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
20 Stoller JK, Aboussouan LS. A review of α1-antitrypsin deficiency. Am J Respir Crit Care Med. 2012;185:246-259. [PMID: 21960536 DOI: 10.1164/rccm.201108-1428CI] [Cited by in Crossref: 253] [Cited by in F6Publishing: 96] [Article Influence: 25.3] [Reference Citation Analysis]
21 Al-Niaimi F, Lyon C. Severe ulcerative panniculitis caused by alpha 1-antitrypsin deficiency: remission induced and maintained with intravenous alpha 1-antitrypsin. J Am Acad Dermatol. 2011;65:227-229. [PMID: 21679830 DOI: 10.1016/j.jaad.2009.11.587] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
22 Greene CM, Hassan T, Molloy K, McElvaney NG. The role of proteases, endoplasmic reticulum stress and SERPINA1 heterozygosity in lung disease and α-1 anti-trypsin deficiency. Expert Rev Respir Med 2011;5:395-411. [PMID: 21702661 DOI: 10.1586/ers.11.20] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
23 Stoller JK, Aboussouan LS. Alpha1-antitrypsin deficiency. Lancet. 2005;365:2225-2236. [PMID: 15978931 DOI: 10.1016/s0140-6736(05)66781-5] [Cited by in Crossref: 386] [Cited by in F6Publishing: 110] [Article Influence: 24.1] [Reference Citation Analysis]
24 Wolf R, Tuzun B, Tuzun Y. Dapsone: unapproved uses or indications. Clinics in Dermatology 2000;18:37-53. [DOI: 10.1016/s0738-081x(99)00093-0] [Cited by in Crossref: 33] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
25 Mordwinkin NM, Louie SG. Aralast: an α 1 -protease inhibitor for the treatment of α-antitrypsin deficiency. Expert Opinion on Pharmacotherapy 2007;8:2609-14. [DOI: 10.1517/14656566.8.15.2609] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
26 Ioachimescu OC, Stoller JK. A Review of Alpha-1 Antitrypsin Deficiency. COPD: Journal of Chronic Obstructive Pulmonary Disease 2009;2:263-75. [DOI: 10.1081/copd-57602] [Cited by in Crossref: 23] [Article Influence: 1.9] [Reference Citation Analysis]
27 Needham M, Stockley RA. Alpha 1-antitrypsin deficiency. 3: Clinical manifestations and natural history. Thorax 2004;59:441-5. [PMID: 15115878 DOI: 10.1136/thx.2003.006510] [Cited by in Crossref: 96] [Cited by in F6Publishing: 76] [Article Influence: 5.6] [Reference Citation Analysis]
28 Greulich T, Ottaviani S, Bals R, Lepper PM, Vogelmeier C, Luisetti M, Ferrarotti I. Alpha1-antitrypsin deficiency – Diagnostic testing and disease awareness in Germany and Italy. Respiratory Medicine 2013;107:1400-8. [DOI: 10.1016/j.rmed.2013.04.023] [Cited by in Crossref: 59] [Cited by in F6Publishing: 41] [Article Influence: 7.4] [Reference Citation Analysis]
29 Wolf R, Orni-wasserlauf R. A century of the synthesis of dapsone: its anti-infective capacity now and then. Int J Dermatol 2000;39:779-83. [DOI: 10.1046/j.1365-4362.2000.00739.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
30 Patterson CC, Jr PR, Pope-harman AL, Knight DA, Magro CM. Alpha-1 anti-trypsin deficiency and Henoch-Schonlein purpura associated with anti-neutrophil cytoplasmic and anti-endothelial cell antibodies of immunoglobulin-A isotype. J Cutan Pathol 2005;32:300-6. [DOI: 10.1111/j.0303-6987.2005.00304.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]